Work

News Beyond Our Pages

Year: 2017

Type: article

Abstract: There is currently a strong need to prevent exacerbations in patients with uncontrolled asthma. Gibson et al (Lancet 2017;390:659-68; https://doi.org/10.1016/S0140-6736(17)31281-3) performed a randomized, double-blind, placebo-controlled trial to assess the effect of the macrolide antibiotic azithromycin on asthma exacerbation frequency. Four hundred twenty patients with severe asthma that was uncontrolled by inhaled corticosteroids or long-acting bronchodilators were assigned to receive 500 mg of oral azithromycin or placebo 3 times per week for 48 weeks.

Source: Journal of Allergy and Clinical Immunology

DOI: 10.1016/j.jaci.2017.09.003

Authors: Marc E. Rothenberg, Jean Bousquet

Language: English

Topic: Asthma and respiratory diseases

Subfield: Physiology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,900

OpenAlex ID: W4235769665

FWCI:

Cites:

Cited by:

Related to: 10